Greenphire Recognized for Sustained Growth; Named to Inc. 5000 List for Eighth Consecutive Year and Philadelphia Business Journal’s Soaring 76 List of Fastest Growing Regional Companies
Global leader in financial solutions for clinical trials continues to expand in U.S. and globally in a transformative year for the industry
King of Prussia, PA – September 29, 2020 – Greenphire, the global leader in financial software solutions for clinical trials, today announced that it has been named to the 2020 Inc. 5000 list, for the eighth straight year. The Inc. 5000 list ranks the nation’s fastest growing private companies in a celebration of their leadership and entrepreneurialism.
Only one percent of the firms on the Inc. 5000 list have been named eight years in a row, which places Greenphire in truly elite company.
Greenphire has also been included in the 2020 Philadelphia Business Journal’s Soaring 76, which honors the fastest growing companies in the metropolitan area. This is the fourth consecutive year that Greenphire has been awarded this designation.
The company has continued impressive growth trajectory even in the face of the pandemic, which has put clinical trials at the forefront of the world’s attention. While supporting more than 1700 total trials globally, Greenphire is directly assisting 10 different pharmaceutical companies completing research for a COVID-19 vaccine.
“The COVID-19 pandemic has been a trying time for the clinical research community and we are proud to be part of the solution for the industry to keep existing trials afoot while also commencing new studies,” said Jim Murphy, CEO of Greenphire. “This past year we’ve grown globally, enhancing our ConneX travel solution and expanded our technology suite with EnvisiX to simplify the budget and negation process. It’s our mission to continue to innovate based on industry needs and we are thrilled that in a time of extreme conditions, such as COVID-19, we were not only able to survive but thrive. Our success is a testament to the incredible team that we’ve built at Greenphire and the resilience of those in the trial community – which we are honored to be a part of.”
Greenphire will be honored at the annual Inc. 5000 event, which will be held virtually from October 19 to 23, 2020.
Greenphire was recognized in a special 2020 Soaring 76 issue of the Philadelphia Business Journal on September 25, 2020.
Greenphire is the leader in global clinical trial financial process automation. Greenphire’s best-in-class solutions optimize clinical trial performance by streamlining payment and logistical workflows from sponsors and CROs to sites and patients. Greenphire’s EnvisiX, eClinicalGPS, ClinCard and ConneX solutions easily handle any type of trial design and complexity, resulting in more accurate and compliant payments and simplified travel globally for both sites and patients. The choice of industry leaders worldwide, Greenphire provides better performance and better data, resulting in better trials. Learn more at www.greenphire.com.